-
Mashup Score: 10
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new late-stage results for CagriSema.
Source: www.statnews.comCategories: General Medicine NewsTweet
-
Mashup Score: 5
Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, raising questions about which dose Novo will pursue.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Dosing questions surround Novo Nordisk next-gen weight loss drug https://t.co/iqdBj5I3FC
-
-
Mashup Score: 5
Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, raising questions about which dose Novo will pursue.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Dosing questions surround Novo Nordisk next-gen weight loss drug https://t.co/iqdBj5I3FC
-
-
Mashup Score: 5DNA Discovery Gives Mysterious Ancient Humans a Face - 7 day(s) ago
Fifteen years after the discovery of a new type of human, the Denisovan, scientists discovered its DNA in a fossilized skull. The key? Tooth plaque.
Source: www.nytimes.comCategories: General Medicine NewsTweet-
DNA Discovery Gives Mysterious Ancient Humans a Face - https://t.co/xjMvTwTnxy
-
-
Mashup Score: 18
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy
-
-
Mashup Score: 18
Gilead’s CEO says he’s committed to making sure people around the world can get his firm’s new HIV prevention shot Yeztugo.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Gilead’s CEO on the approval of a powerful new drug to prevent HIV Daniel O’Day says he’s committed to making sure that people around the world can get his company’s new injection https://t.co/iDXvJbkecy
-
-
Mashup Score: 6U.K. decision blocks a pair of Alzheimer’s drugs from access through its national health service - 8 day(s) ago
A U.K. health agency said the Alzheimer’s drugs Kisunla and Leqembi are not cost-effective, meaning they won’t be offered through the NHS.
Source: www.statnews.comCategories: General Medicine NewsTweet-
U.K. says Alzheimer's drugs Kisunla, Leqembi aren't cost-effective https://t.co/NFaeTCObtB
-
-
Mashup Score: 15Top gene therapy regulator forced out at FDA - 8 day(s) ago
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her deputy Rachael Anatol have been
Source: www.statnews.comCategories: General Medicine NewsTweet-
Nicole Verdun, top gene therapy regulator, is out at FDA https://t.co/kordWh13fZ
-
-
Mashup Score: 2Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys - 8 day(s) ago
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t getting answers from Sarepta.
Source: www.statnews.comCategories: General Medicine NewsTweet-
Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys https://t.co/0CXj82XJXm
-
-
Mashup Score: 3Vaccine advisers to consider MMRV vaccines, 'thimerosal containing' flu shots in pared-down meeting - 8 day(s) ago
RFK Jr.’s handpicked advisers will discuss two long-approved shots at their next meeting
Source: www.statnews.comCategories: General Medicine NewsTweet-
Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu shots in pared-down meeting https://t.co/ws5TXARJu0
-
Novo Nordisk’s next-gen obesity drug results a letdown for investors, but not physicians, @elaineywchen writes. https://t.co/9rRdQpLDOg